Cargando…
Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study
Objective To assess the risk of systemic adverse events associated with intravitreal injections of vascular endothelial growth factor inhibiting drugs. Design Population based nested case-control study. Setting Ontario, Canada. Participants 91 378 older adults with a history of physician diagnosed r...
Autores principales: | Campbell, Robert J, Gill, Sudeep S, Bronskill, Susan E, Paterson, J Michael, Whitehead, Marlo, Bell, Chaim M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389519/ https://www.ncbi.nlm.nih.gov/pubmed/22763393 http://dx.doi.org/10.1136/bmj.e4203 |
Ejemplares similares
-
Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach
por: Petri, Anne-Sofie, et al.
Publicado: (2020) -
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023) -
Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
por: Wang, Donghyun, et al.
Publicado: (2014) -
Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021) -
Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections
por: Ahmed, Umar, et al.
Publicado: (2022)